TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,688 | +264.5% | 363 | +266.7% | 0.00% | – |
| Q2 2023 | $3,755 | +56.0% | 99 | 0.0% | 0.00% | – |
| Q1 2023 | $2,407 | -19.8% | 99 | +12.5% | 0.00% | – |
| Q4 2022 | $3,000 | +50.0% | 88 | +22.2% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 72 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 72 | -19.1% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 89 | +102.3% | 0.00% | – |
| Q4 2021 | $2,000 | -80.0% | 44 | -72.5% | 0.00% | – |
| Q3 2021 | $10,000 | 0.0% | 160 | +17.6% | 0.00% | – |
| Q2 2021 | $10,000 | 0.0% | 136 | +3.8% | 0.00% | – |
| Q1 2021 | $10,000 | +233.3% | 131 | +274.3% | 0.00% | – |
| Q4 2020 | $3,000 | -76.9% | 35 | -84.8% | 0.00% | – |
| Q3 2020 | $13,000 | -13.3% | 231 | +4.5% | 0.00% | – |
| Q2 2020 | $15,000 | +7.1% | 221 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | – | 221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |